Airway diseases
Respiratory critical care
Sleep and breathing disorders
Symposium
The many faces of central sleep apnoea and hypoventilation syndromes
Clinical
Aims : to discuss the phenotypes of central sleep apnoea and the impact of biomarkers on outcomes, new pathophysiological insights and consecutive therapeutic options for obesity hypoventilation, the strengths and limitations of positive airway pressure during the lifetime and the relevance of concomitant pulmonary disease with not only obstructive, but also central, sleep apnoea.
Target audience :
Adult pulmonologist/Clinician, Clinical researcher, General practitioner, Medical Student, Medical Technical Assistant, Nurse, Respiratory critical care physician, Physician in Pulmonary Training, Scientist (basic, translational)
Methods :
General respiratory patient care, Public health, Respiratory intensive care
11:15
Phenotyping and prognostic markers of central sleep apnoea: is treatment of central sleep apnoea necessary?
W. Randerath(Solingen, Germany)
COI
-
Description
1
3696
11:30
Opioid-induced central sleep apnoea: exceptional or epidemic ?
S. Javaheri(Cincinnati, United States)
COI
-
Description
2
3697
11:45
New perspectives in obesity hypoventilation: from pathophysiology to treatment
J. Pépin(Grenoble, France)
COI
-
Description
3
3698
12:00
Continuous positive airway pressure and non-invasive ventilation in hypoventilation syndromes from childhood to adulthood
M. Duiverman(Groningen, Netherlands)
COI
-
Description
4
3699
12:15
Discussion and Q&A
5
3700
. . .
